Research

uMed is a health technology company that connects you to research studies which may benefit you and help advance medicine.

Your healthcare provider has partnered with uMed to help offer opportunities to participate in medical research that is most relevant for you. This is having a huge impact on the development of new treatments and cures.

We will never use your data for any purpose other than to contact you on behalf of your GP about research that you may be interested in. If you do not want to participate in any research opportunities then you can opt out anytime. 

HARMONIE – Protecting babies from RSV

Join this international research study that aims to understand how strongly babies can be protected from serious illness due to RSV infection (respiratory syncytial virus) by giving them a single antibody dose.

RSV is a common seasonal virus that infects nearly all babies by their second birthday. Most of the time it causes a mild illness, like a cold. However, for some babies it leads to more severe lung problems such as bronchiolitis and pneumonia.

The antibody dose in the HARMONIE study has already been given to more than 3000 babies, and several studies have been completed and have shown this antibody dose to work well.

As many as 28,860 babies in the UK, France, and Germany will take part in the HARMONIE Study.

By taking part in this study you will be helping to establish whether offering this vaccine to all babies in the UK can reduce the number of hospitalisations as a result of RSV.

Who can participate?

This study will include newborn babies to babies 12 months old who are in, or are approaching, their first RSV season.

How can I get involved in this study?

If your infant meets the criteria of this study, you will receive a text message, email or letter from us with more information and inviting you to be involved.

We work with a health technology company called uMed who are helping us to offer you more opportunities to participate in medical research that is most relevant to you. They will be available to support you with any questions regarding this study and their contact information will be on all of the communication you receive from us.

ACCESS-PD – improving research into Parkinson’s Disease

Join this nationwide study that aims to improve our understanding of Parkinson’s Disease so that new treatments can be developed to slow the progression or even prevent this disease in the future.

Access-PD is a type of study called a registry, or research database, that follows patients with Parkinson’s Disease over time. As part of this registry you will be asked to contribute information about your health, but you can participate at home and you are not required to visit your GP or a hospital.

Based on you being a part of the Access-PD registry, you may also be invited to register for future studies which could require a GP or hospital visit, but it would always be your choice whether to participate or not.

Your involvement in this study will play a vital role in supporting the development of more advanced treatments that could improve the lives of more than 130,000 people diagnosed with Parkinson’s Disease in the UK.

Who can participate?

To participate in this research study you must be diagnosed with Parkinson’s Disease.

How can I get involved in this study?

If you meet the criteria of this study, you will receive a text message, email or letter from us inviting you to be involved.

We work with a health technology company called uMed who are helping us to offer you more opportunities to participate in medical research that is most relevant to you. They will be available to support you with any questions regarding this study and their contact information will be on all of the communication you receive from us.

Patient study support line on 020 7861 4428 or patientsupport@umed.io